The rate of full COVID-19 vaccination among employees of a private Minnesota medical device manufacturer rose 10.4 percentage points after the company began offering $1,000 incentives for immunization, finds a study published late last week in JAMA Network Open.
The estimated effectiveness of the Pfizer/BioNTech COVID-19 vaccine against infection in US adolescents was 91%, with 93% protection against symptomatic illness and 85% against asymptomatic disease amid the Delta SARS-CoV-2 surge in Connecticut, finds a study published yesterday in JAMA Network Open.
In a randomized controlled trial in France, a statin drug failed to improve survival rates in patients with ventilator-associated pneumonia (VAP), according to a report published online today by the Journal of the American Medical Association (JAMA).
